3-{[4-methyl-5-(3-pyridinyl)-4H-1,2,4-triazol-3-yl]thio}propanoic acid, 95.0%, 1g

5-Fluoronicotinaldehyde, 95.0%, 5g

tert-Butyl 7-hydroxy-7,8-dihydro-4H-pyrazolo[1,5-a][1,4]diazepine-5(6H)-carboxylate, 95%, 250mg

4-Ethynyl-2-fluorobenzaldehyde, 250mg

tert-Butyl N-[(3S)-1-(pyrimidin-2-yl)pyrrolidin-3-yl]carbamate, 1g

3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)isonicotinonitrile, 95.0%, 250mg

Lithium nitrate, min. 99.5%, anhydrous, 500 g, plastic packaging.

1-Bromo-4-pentyloxybenzene, 95.0%, 1g

3-(3,5-Dimethyl-isoxazol-4-yl)-propionic acid, 95.0%, 10g

4-Chloro-2,5-difluorobenzamide, 98%, 100mg

Methyl 6-chloropyrimidine-4-carboxylate, 97.0%, 25g

2-ethoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol, 95.0%, 1g

(2-Chloroethyl)phosphonic Acid>98.0%(T)1g